|
1) Dor Y, Brown J, Martinez OI, et al. Adult pan-creatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature. 2004; 429: 41-6
|
|
|
|
2) Rhodes CJ. Type 2 diabetes-a matter of beta-cell life and death？ Science. 2005; 307: 380-4
|
|
|
|
|
|
3) Ackermann AM, Gannon M. Molecular regulation of pancreatic beta-cell mass development, maintenance, and expansion. J Mol Endocrinol. 2007; 38: 193-206
|
|
|
|
|
|
4) Karnik SK, Chen H, McLean GW, et al. Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus. Science. 2007; 318: 806-9
|
|
|
|
|
|
5) Terauchi Y, Takamoto I, Kubota N, et al. Gluco-kinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. J Clin Invest. 2007; 117: 246-57
|
|
|
|
|
|
6) Ueki K, Okada T, Hu J, et al. Total insulin and IGF-I resistance in pancreatic beta cells causes overt diabetes. Nat Genet. 2006; 38: 583-8
|
|
|
|
|
|
7) Hashimoto N, Kido Y, Uchida T, et al. Ablation of PDK1 in pancreatic beta cells induces diabetes as a result of loss of beta cell mass. Nat Genet. 2006; 38: 589-93
|
|
|
|
|
|
8) Okada T, Liew CW, Hu J, et al. Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance. Proc Natl Acad Sci U S A. 2007; 104: 8977-82
|
|
|
|
|
|
9) Chick WL, Like AA. Studies in the diabetic mutant mouse. 3. Physiological factors associated with alterations in beta cell proliferation. Diabetologia. 1970; 6: 243-51
|
|
|
|
|
|
10) Edvell A, Lindstrom P. Initiation of increased pancreatic islet growth in young normoglycemic mice (Umea ＋/？). Endocrinology. 1999; 140: 778-83
|
|
|
|
|
|
11) Utzschneider KM, Prigeon RL, Carr DB, et al. Impact of differences in fasting glucose and glucose tolerance on the hyperbolic relationship between insulin sensitivity and insulin responses. Diabetes Care. 2006; 29: 356-62
|
|
|
|
|
|
12) Michael MD, Kulkarni RN, Postic C, et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dys-function. Mol Cell. 2000; 6: 87-97
|
|
|
|
|
|
13) Bruning JC, Michael MD, Winnay JN, et al. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell. 1998; 2: 559-69
|
|
|
|
|
|
14) Bluher M, Michael MD, Peroni OD, et al. Adipose tissue selective insulin receptor knockout pro-tects against obesity and obesity-related glucose intolerance. Dev Cell. 2002; 3: 25-38
|
|
|
|
|
|
15) Yamada T, Katagiri H, Ishigaki Y, et al. Signals from intra-abdominal fat modulate insulin and leptin sensitivity through different mechanisms: neuronal involvement in food-intake regulation. Cell Metab. 2006; 3: 223-9
|
|
|
|
|
|
16) Uno K, Katagiri H, Yamada T, et al. Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity. Science. 2006; 312: 1656-9
|
|
|
|
|
|
17) Imai J, Katagiri H, Yamada T, et al. Cold exposure suppresses serum adiponectin levels through sympathetic nerve activation in mice. Obesity(Silver Spring). 2006; 14: 1132-41
|
|
|
|
|
|
18) Katagiri H, Yamada T, Oka Y. Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals. Circ Res. 2007; 101: 27-39
|
|
|
|
|
|
19) Imai J, Katagiri H, Yamada T, et al. Regulation of Pancreatic {beta} Cell Mass by Neuronal Signals from the Liver. Science. 2008; 322: 1250-4
|
|
|
|
|
|
20) Gautam D, Han SJ, Hamdan FF, et al. A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Cell Metab. 2006; 3: 449-61
|
|
|
|
|
|
21) Kiba T, Tanaka K, Numata K, et al. Ventromedial hypothalamic lesion-induced vagal hyperactivity stimulates rat pancreatic cell proliferation. Gastroenterology. 1996; 110: 885-93
|
|
|
|
|
|
22) Edvell A, Lindstrom P. Vagotomy in young obese hyperglycemic mice: effects on syndrome develop-ment and islet proliferation. Am J Physiol. 1998; 274: E1034-9
|
|
|
|
|
|
23) Yang S, Lin HZ, Hwang J, et al. Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant con-dition？ Cancer Res. 2001; 61: 5016-23
|
|
|
|
|
|
24) Gum RJ, Gaede LL, Heindel MA, et al. Antisense protein tyrosine phosphatase 1B reverses acti-vation of p38 mitogen-activated protein kinase in liver of ob/ob mice. Mol Endocrinol. 2003; 17: 1131-43
|
|
|
|
|
|
25) Fujishiro M, Gotoh Y, Katagiri H, et al. Three mitogen-activated protein kinases inhibit insulin signaling by different mechanisms in 3T3-L1 adipocytes. Mol Endocrinol. 2003; 17: 487-97
|
|
|
|
|
|
26) Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006; 444: 881-7
|
|
|
|
|
|
27) Butler AE, Janson J, Bonner-Weir S, et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003; 52: 102-10
|
|
|
|
|
|
28) Ishihara H, Takeda S, Tamura A, et al. Disruption of the WFS1 gene in mice causes progressive beta-cell loss and impaired stimulus-secretion coupling in insulin secretion. Hum Mol Genet. 2004; 13: 1159-70
|
|
|
|
|
|
29) Katagiri H, Imai J, Oka Y. Neural relay from the liver induces proliferation of pancreatic β cells: A path to regenerative medicine using the self-renewal capabilities. Commun Integr Biol. In press
|
|
|
|
|